Skaug K, Mørkve O, Gulsvik A
Medisinsk avdeling Fylkessjukehuset i Haugesund 5513 Haugesund.
Tidsskr Nor Laegeforen. 2001 Aug 10;121(18):2155-8.
We have studied how patients with obstructive lung disease are treated in Norwegian hospitals and whether the treatment is in accordance with international guidelines.
During 76 days from 1 April 1997 we registered all 176 patients (110 women) admitted for obstructive lung disease in two hospital catchment areas in western Norway. The medical treatment given the first three hours after admission was recorded by the doctors on call.
106 patients (60%) were above 65 years of age; 21 (12%) below 35.31% of the patients had a mild form of the disease, 42% a moderate, 21% a severe, and 6% a life-threatening condition. Almost all patients with moderate and severe disease were treated with beta 2 agonists on admission. Among the patients with moderate disease, 25% did not receive glucocorticoids during the first three hours in hospital. The proportion of patients treated with theophylline was lower among those with mild disease than among those with moderate disease (15% and 65% respectively).
Guidelines are followed to a high degree in patients with severe or life threatening obstructive lung disease, but only party in those with mild or moderate disease.
我们研究了挪威医院中阻塞性肺病患者的治疗方式以及治疗是否符合国际指南。
在1997年4月1日起的76天里,我们记录了挪威西部两个医院服务区域内收治的所有176例阻塞性肺病患者(110名女性)。值班医生记录了入院后头三个小时内给予的治疗。
106例患者(60%)年龄在65岁以上;21例(12%)年龄在35岁以下。31%的患者病情较轻,42%为中度,21%为重度,6%为危及生命的情况。几乎所有中度和重度患者入院时都接受了β2受体激动剂治疗。在中度病情患者中,25%在入院后头三个小时内未接受糖皮质激素治疗。轻度病情患者中接受茶碱治疗的比例低于中度病情患者(分别为15%和65%)。
重度或危及生命的阻塞性肺病患者在很大程度上遵循了指南,但轻度或中度病情患者仅部分遵循。